Endometrial Ablation Devices Market Size to Reach USD 1,596.9 Million in 2028 Growing at a CAGR of 5.3%, according to Emergen Research
Emergen Research has published its latest report titled “Endometrial Ablation Devices Market Size, Share, Trends, By Technology Type (Cryoablation, Radiofrequency Ablation, Hysteroscopic Ablation, Thermal Balloon, Hydrothermal Ablation), By End-use (Ambulatory Surgery Center, Hospital, Clinic), and By Region Forecast to 2028”
According to Emergen Research, the global endometrial ablation devices market size was USD 1,049.9 million in 2020 and is expected to reach USD 1,596.9 million in 2028 and register a revenue CAGR of 5.3% during the forecast period, 2021-2028.
Heavy menstrual bleeding can be treated with a minimally invasive surgical procedure known as endometrial ablation. The procedure works by ablating the tissue (known as endometrium) in the lining of the uterus. As the endometrium causes bleeding, destroying it can reduce menstrual bleeding to a normal level or even decrease it. According to the U.S. Food & Drug Administration (FDA), heavy menstrual bleeding is a condition that many women face. Approximately one-third of people who get their period seek treatment for excessive bleeding. Bleeding that totals more than 1/3 cup (80 ml) is termed heavy or excessive. This increasing number of patients suffering from menorrhagia which refers to heavy/abnormal menstrual bleeding situations is a major factor expected to positively impact market revenue growth over the forecast period.
Technological advancements in healthcare equipment and rise in research activities on the methods used to destroy or remove endometrium are other factors expected to boost market growth. The different methods include electrosurgery, cryoablation, free-flowing hot fluid, radiofrequency and microwave that improves patient outcomes. However, side effects of endometrial ablation such as cramping, nausea, temporary diarrhea, pain, vaginal bleeding/ discharge/spotting after the surgery can restrain market revenue growth. In addition, availability of alternative treatment options such as drug therapies (non-hormonal and hormonal) and hysterectomy can hamper growth of the global market to a certain extent over the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/765
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Radiofrequency Ablation Segment Revenue to Expand at a Rapid CAGR:
Radiofrequency ablation segment is expected to register a rapid revenue CAGR over the forecast period due to its convenience, effectivity, and less risk associated with it and increasing prevalence of gynecology disorders. A radio-frequency endometrial ablation is a procedure in which radio-frequency energy is used to thin the lining of uterus. Most women see a noticeable reduction in their cycles after the operation, and other women experience no periods at all.
Clinic Segment to Register Significant Revenue Growth:
Clinic segment is expected to register significant revenue growth over the forecast period owing to introduction of advanced technologies for treating menorrhagia, rising awareness regarding the use of endometrial ablation devices, growing clinical trials on endometrial ablation techniques and increasing government budget allocation on the ease availability of healthcare devices.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to large scale use of advanced technologies such as medical robotics in surgical operations, rising healthcare expenditure, and favorable government regulations regarding use of such devices. Endometrial ablation devices have been approved by US FDA for premenopausal women who have heavy monthly flow owing to benign (non-cancerous) causes and have finished child bearing. On September 28, 2001, US FDA authorized NovaSure (developed by Hologic) as a device for endometrial ablation.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/765
Major Companies in the Market Include:
- Boston Scientific Corporation
- Olympus Corporation
- Smith & Nephew plc. (Medtronic plc.)
- Idoman Teoranta, AEGEA Medical, Inc.
- CooperSurgical Inc.
- Richard Wolf GmbH
- Hologic, Inc.
- Johnson & Johnson
- Minerva Surgical, Inc.
For the purpose of this report, Emergen Research has segmented the global endometrial ablation devices market on the basis of technology type, end-use, and region:
Technology Type Outlook (Revenue, USD Million; 2018–2028)
- Radiofrequency Ablation
- Hysteroscopic Ablation
- Thermal Balloon
- Hydrothermal Ablation
End-use Outlook (Revenue, USD Million; 2018–2028)
- Ambulatory Surgery Center
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
The global micro mobility market size is expected to reach USD 290.39 Billion by 2028, at a CAGR of 18.8% during the forecast period. Market revenue growth is primarily driven by increasing traffic congestion and longer urban commutes.
The global vehicle-to-everything (V2X) market size was USD 677.9 Million in 2020 and is projected to reach a market size of USD 11.27 Billion in 2028 and register a CAGR of 41.8% during the forecast period. Rising incidence of road accidents is a key factor driving demand for vehicle-to-everything communications.
The global solar vehicle market size was USD 290.7 Million in 2020, which is expected to reach USD 2,899.7 Million in 2027 and register a robust double-digit CAGR of 38.9% during the forecast period. Market growth is primarily driven by rising interest in renewable and sustainable energy resources and systems.
The global driving simulator market size reached USD 4.56 Billion in 2020 and is expected to register a steady CAGR of 3.3% during the forecast period. Rising focus and growing investment in research and development activities, technological advancements, increasing adoption of driving simulation technologies by car manufacturing companies, and rapid advancements in autonomous vehicles are some key factors boosting revenue growth of the global driving simulator market.
The global automotive airbag silicone market size reached USD 237.5 Million in 2020 and is expected to register a CAGR of 15.4% during the forecast period. Growing number of silicone-coated airbags per vehicle is a key factor expected to drive global automotive airbag silicone market growth during the forecast period.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756